Page 11 - Tim Crew News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Senior Editor Lannett has added a new co-development agreement for biosimilar insulin Aspart with its strategic alliance partners within the HEC Group of companies. Insulin Aspart, a short-acting (fast-acting) insulin typically taken just before eating, is used to treat adults with Type 1 and Type 2 diabetes for the control of high blood sugar. Total U.S. sales for the 12 months ended December 2020 of various insulin asparts, including Novo Nordisk’s NovoLog, exceeded $6 billion, according to IQVIA, although actual biosimilar market values are expected to be lower. Insulin Asp...

Senior Editor Lannett is offering chlorpromazine hydrochloride tablets in dosage strengths of 10 mg, 25 mg, 50 mg, 100 mg and 200 mg. Lannett’s product is the generic of GlaxoSmithKline’s Thorazine. Thorazine had a market value of approximately $120 million for the 12 months ended November 2020, according to IQVIA, although actual generic market values are expected to be lower, "Chlorpromazine hydrochloride tablets, an internally developed product, is used to treat psychotic disorders such as schizophrenia or manic-depression in adults," said Tim Crew, CEO of Lannett. "We ex...

Operator Welcome to the Lannett Company's Fiscal 2021 Second Quarter Financial Results Conference Call. My name is Adrian. I will be your operator for today's call. [Operator Instructions] Please note that this conference is being recorded. I will now turn the call over to Robert Jaffe. Robert Jaffe, you may begin. Robert Jaffe Good afternoon, everyone. And thank you for joining us today to discuss Lannett Company's fiscal 2021 second quarter financial results. On the call today are Tim Crew, Chief Executive Officer; and John Kozlowski, the company's Chief Financial Officer; and Maureen Cavan...